$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
$80.22M
Market Cap
-
P/E Ratio
-2.9
EPS
$16.94
52 Week High
$1.80
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
CervoMed Inc. is a Boston-based clinical-stage biotechnology company focused on developing groundbreaking therapeutics for neurodegenerative diseases, notably Alzheimer's and Parkinson's. Leveraging cutting-edge research methodologies and a strong drug pipeline, the company addresses significant unmet medical needs within this complex therapeutic landscape. With its dedication to innovation and strategic drug development, CervoMed holds potential as a transformative force in treatment paradigms, presenting compelling opportunities for both patient outcomes and investor value.
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK